| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 761.41M | $ 675.04M | $ 482.38M | $ 401.86M | $ 365.98M |
| Gross Profit | $ 748.43M | $ 664.16M | $ 475.89M | $ 396.47M | $ 360.70M |
| Operating Income | $ 44.80M | $ 136.95M | $ 107.28M | $ 112.63M | $ 124.48M |
| EBITDA | $ 68.35M | $ 162.83M | $ 125.60M | $ 117.45M | $ 127.95M |
| Net Income | $ 99.65M | $ 139.73M | $ 106.14M | $ 101.42M | $ 112.51M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 372.15M | $ 383.33M | $ 368.22M | $ 431.67M | $ 223.53M |
| Total Assets | $ 836.65M | $ 840.55M | $ 621.52M | $ 583.43M | $ 423.76M |
| Total Debt | $ 6.11M | $ 6.94M | $ 151.00K | $ 1.14M | $ 526.00K |
| Net Debt | $ -114.39M | $ -120.73M | $ -135.40M | $ -65.19M | $ -77.09M |
| Total Liabilities | $ 188.85M | $ 160.96M | $ 114.81M | $ 81.59M | $ 47.95M |
| Stockholders' Equity | $ 647.80M | $ 679.59M | $ 506.70M | $ 501.84M | $ 375.81M |
| Cash Flow | |||||
| Free Cash Flow | $ 141.78M | $ 195.90M | $ 126.90M | $ 119.91M | $ 167.42M |
| Operating Cash Flow | $ 142.00M | $ 198.07M | $ 127.04M | $ 120.32M | $ 167.89M |
| Investing Cash Flow | $ 69.76M | $ -177.60M | $ 90.91M | $ -114.33M | $ 136.13M |
| Financing Cash Flow | $ -220.37M | $ -28.35M | $ -148.72M | $ -17.28M | $ -302.59M |
Corcept Therapeutics Inc. (CH:HTD)
:HTD
